Author:
Ningthoujam Rina,Chanu Naorem BidyaLeima,Anumala Vivek,Babu Punuri Jayasekhar,Pradhan Srimay,Panda Manasa Kumar,Heisnam Punabati,Singh Yengkhom Disco
Reference87 articles.
1. Chung, C., & Christianson, M. (2014). Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation. Journal of Oncology Pharmacy Practice, 20(1), 11–28.
2. Pezo, R. C., & Bedard, P. L. (2015) Definition: Translational and personalised medicine, biomarkers, pharmacodynamics. ESMO Handbook of Translational Research.
3. Carlomagno, N., Incollingo, P., Tammaro, V., Peluso, G., Rupealta, N., Chiacchio, G., Sandoval Sotelo, M. L., Minieri, G., Pisani, A., Riccio, E., & Sabbatini, M. (2017). Diagnostic, predictive, prognostic, and therapeutic molecular biomarkers in third millennium: A breakthrough in gastric cancer. BioMed Research International.
4. Animesh, S., Singh, Y. D. (2021). A comprehensive study on aptasensors for cancer diagnosis. Current Pharmaceutical Biotechnology, 1;22(8), 1069–1084.
5. Durães, C., Almeida, G. M., Seruca, R., Oliveira, C., & Carneiro, F. (2014). Biomarkers for gastric cancer: Prognostic, predictive or targets of therapy? VirchowsArchiv, 464(3), 367–378.